Guests/Speakers
Janet Freeman-Daily, Dr.Jonathan Goldman
Immunotherapy has given doctors a new level of treatment – a new tool in the arsenal.
In this discussion between patient advocate Janet Freeman Daily and Dr. Jonathan Goldman from the Ronald Reagan UCLA Medical Center, learn the answers to these questions:
- Where does immunotherapy fit as a lung cancer treatment?
- Which treatment is better – targeted therapy or immunotherapy?
- How do you determine whether immunotherapy is a treatment to use?
- Can you use immunotherapy for metastatic lung cancer?
How do cancers evade our immune system?
Spontaneous mutations in the genes of a cancer cell cause the cells to be altered in such a way that our bodies can no longer recognize them as something foreign. They can also produce substances or proteins that can shield them from immune attack.
Clinical trials are ongoing and new, effective immunotherapy treatments are being tested, evaluated, and FDA-approved regularly. Combinations of these drugs with chemotherapy and/or other targeted therapies are also being investigated and several combinations have been approved by the Federal Drug Administration (FDA) for the treatment of certain NSCLC and SCLC patients.
LCFA’s Hope With Answers℠ video series provides essential information for those newly diagnosed with lung cancer.
Available online, anytime you need it and anywhere you are, Hope With Answers℠ videos pair lung cancer patients with leading lung cancer doctors. The patients ask the questions that matter most to lung cancer patients. And, they get the answers from doctors who specialize in lung cancer. These lung cancer specialists dedicate their careers to staying up to date on the best tests, the latest effective treatment options, and what exciting things are on the horizon to help lung cancer patients.
